期刊文献+

GDF-15水平与2型糖尿病肾病分期相关性Meta分析 被引量:1

Relationship between GDF-15 level and staging of diabetic nephropathy:a meta-analysis
下载PDF
导出
摘要 目的探讨生长分化因子-15(GDF-15)水平与糖尿病肾病(DN)不同分期的关系。方法在CNKI、PubMed、Cochrane Library、万方数据库、维普数据库检索自建库以来至2020年7月公开发表的有关GDF-15与DN关系的相关文献,采用Revman 5.3和Stata 12.0软件进行Meta分析。结果本研究共纳入9篇文献,Meta分析结果显示,微量白蛋白尿组GDF-15水平高于正常白蛋白尿组[SMD=0.87,95%CI:0.42~1.33,P<0.05],大量白蛋白尿组GDF-15水平高于微量白蛋白尿组[SMD=2.57,95%CI:1.01~4.13,P<0.05]和正常白蛋白尿组[SMD=3.49,95%CI:1.84~5.15,P<0.05]。结论DN患者血清GDF-15水平随其疾病严重程度加重而升高,测定GDF-15水平对判断DN病情有指导意义。 Objective To explore the relationship between the level of growth differentiation factor-15(GDF-15)and staging of diabetic nephropathy by meta-analysis.Methods The articles about GDF-15 and diabetic nephropathy published from CNKI,Pubmed,Cochrane Library,Wanfang database and VIP database before July 2020 were analyzed by Revman 5.3 and Stata 12.0.Results A total of 9 articles were included in this study.Meta-analysis showed that the level of GDF-15 in microscale albuminuria group was higher than that in normal albuminuria group(SWD=0.87,95%CI:0.42~1.33,P<0.05),and GDF-15 level in macro albuminuria group was higher than that in microscale albuminuria group(SMD=2.57,95%CI:1.01~4.13,P<0.05)and normal albuminuria group(SMD=3.49,95%CI:1.84~5.15,P<0.05).Conclusion The serum GDF-15 level in diabetic nephropathy increases with the disease severity,and the determination of GDF-15 may has clinical significance.
作者 周佳奇 梁栋 周琪 张慧 张清潭 ZHOU Jiaqi;LIANG Dong;ZHOU Qi;ZHANG Hui;ZHANG Qingtan(Department of Geriatrics,Binzhou Medical University Hospital,Binzhou 256600,China)
出处 《浙江医学》 CAS 2021年第16期1785-1789,共5页 Zhejiang Medical Journal
关键词 糖尿病肾病 生长分化因子-15 META分析 Diabetic nephropathy Growth differentiation factor-15 Meta-analysis
  • 相关文献

参考文献7

二级参考文献44

  • 1Montserrat B Duran-Salgado,Alberto F Rubio-Guerra.Diabetic nephropathy and inflammation[J].World Journal of Diabetes,2014,5(3):393-398. 被引量:178
  • 2Zachary TB. Diabetes: East meets West. The joint american association of clinical endocrinologists-Chinese society of endocrinology(AACE-CSE)symposium[J]. J Diabetes, 2012, 4(3): 221-6.
  • 3Oq'mre AM, Hailpem SM, Pavkov ME, et al. Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes[J]. Arch Intern Med, 2010, 170(11): 930-6.
  • 4Eggers KM, Kempf T, Lagerqvist B, et al. factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome [J]. Circ Cardiovasc Genet, 2010, 3(1): 88-96.
  • 5Anand IS, Kempf T, Rector TS, et al. Serial measurement of growth- differentiation factor-15 in heart failure:relation to disease severity and prognosis in the valsartan heart failure trial [J]. Circulation, 2010, 122(14): 1387-95.
  • 6Maria L, Hans HE Anders J, et al. Plasma growth differentiation factor-15 independently predicts All-Cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy[J]. Diabetes Care, 2010, 33(7): 1567-72.
  • 7Merel EH, Dick DZ, Magdalena M, et al. Growth-Differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes[J]. Diabetes Care, 2012, 35(11): 2340-6.
  • 8Bootcov MR, Bauskin AR, Valenzuela SM, et al. MIC-1, a novelmacrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily cluster[J]. Proc Natl Acad Sci USA, 1997, 94 (21): 11514-9.
  • 9成丹,李启富,程庆丰.血清MIC-1与2型糖尿病的相关陛研究[C].2009年脂质代谢与器官损害国际学术研讨会论文摘要集,2009.
  • 10Teresa AZ, Xiao L J, Edward CH, et al. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury[J]. Shock, 2005, 23(6): 543-8.

共引文献51

同被引文献19

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部